Catherine E. Snider - Concepedia

Concepedia

Author

Catherine E. Snider

The Ohio State University

Also Known As

C E Snider, C Snider, C. Snider, C.E. Snider, CATHERINE E. SNIDER, Catherine E. Snider

27

Publications

1.2K

Citations

14

H-Index

31

Concepts

All Affiliations

The Ohio State University Procter & Gamble (United States)Boston Medical Center Harvard University Beth Israel Deaconess Hospital

CE

About

Catherine E. Snider is an author at The Ohio State University specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	469
2	Biochemistry	7	7	406
3	Natural Sciences	6	6	407
4	Cell Biology	2	2	205
5	Health Sciences	1	1	12

Catherine E. Snider

×

15

Publications

1.2K

Citations

13

H-Index

	Year	Citations
Ligand-Modulated Regulation of Progesterone Receptor Messenger Ribonucleic Acid and Protein in Human Breast Cancer Cell Lines Linnea D. Read, Catherine E. Snider, Jean S. Miller, Molecular Endocrinology	1988	214
Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells. Diane P. Williams, Catherine E. Snider, Terry B. Strom, Journal of Biological Chemistry Native Diphtheria ToxinCytokineSignal TransductionTarget CellsMedicine	1990	185
Purified human growth hormone from E. coli is biologically active K. C. Olson, James Fenno, Norman Lin, Nature E. ColiProtein ExpressionGrowth HormoneBiochemistryHuman Growth	1981	138
Interleukin 2 receptor‐targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin‐related interleukin 2 fusion protein into cells Cory A. Waters, Patricia A. Schimke, Catherine E. Snider, European Journal of Immunology	1990	113
Design and Synthesis of Piperazine-Based Matrix Metalloproteinase Inhibitors Menyan Cheng, Biswanath De, Stanisław Pikul, Journal of Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryBiochemistryPiperazine-based Mmp InhibitorsNatural Sciences	2000	98
Design and Synthesis of Phosphinamide-Based Hydroxamic Acids as Inhibitors of Matrix Metalloproteinases Stanisław Pikul, Kelly L. McDow Dunham, Neil G. Almstead, Journal of Medicinal Chemistry	1998	84
Discovery of Potent, Achiral Matrix Metalloproteinase Inhibitors Stanisław Pikul, Kelly L. McDow Dunham, Neil G. Almstead, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryDonut IconGamble Pharmaceuticals	1998	79
Potent enzyme-activated inhibition of aromatase by a 7 alpha-substituted C19 steroid. Catherine E. Snider, Robert W. Brueggemeier Journal of Biological Chemistry	1987	53
Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells Tetsuyuki Kiyokawa, Diane P. Williams, Catherine E. Snider, Protein Engineering Design and Selection	1991	48
7 α -Substituted androstenediones as effective in vttro and invivo inhibitors of aromatase Robert W. Brueggemeier, Pui‐Kai Li, Catherine E. Snider, Steroids Molecular PharmacologyBiochemistryMedicineMechanism Of ActionAromatase	1987	46

Page 1